Suchergebnisse - "Ampelioti, Sevasti"

PubPharm (7)

1

Switching from omalizumab to mepolizumab in severe asthmatics : A post hoc analysis of the RELight study

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2024

von Kallieri, M. | Papaioannou, A. | Zervas, E. | +31

2

The Real Impact of Age on Mortality in Critically Ill COVID-19 Patients

enthalten in: Journal of personalized medicine | 2023

von Bakakos, A. | Koukaki, E. | Ampelioti, S. | +5

3

RELIght : A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response

enthalten in: Allergy | 2022

von Kallieri, M. | Zervas, E. | Fouka, E. | +31

4

Fungal Infections in Critically Ill COVID-19 Patients : Inevitabile Malum

enthalten in: Journal of clinical medicine | 2022

von Rovina, N. | Koukaki, E. | Romanou, V. | +5

5

RELIght : A two‐year REal‐LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response

enthalten in: Allergy | 2022

von Kallieri, M. | Zervas, E. | Fouka, E. | +31

6

Mepolizumab in Severe Eosinophilic Asthma : A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis

enthalten in: International archives of allergy and immunology | 2020

von Kallieri, M. | Zervas, E. | Katsoulis, K. | +22

7

Acid-Base Disturbances in Patients with Asthma : A Literature Review and Comments on Their Pathophysiology

enthalten in: Journal of clinical medicine | 2019

von Vasileiadis, I. | Alevrakis, E. | Ampelioti, S. | +3

1
[1]